← back to search

Jessica C. Stark

Massachusetts Institute of Technology · US
Area of research
Molecular Biology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include SIGLEC, Biology, Glycoprotein, Computational biology, Chemistry, and Glycosylation.
h-index
citations
1,385
works
18
NIH funding
primary concept
email

Recent publications

Antibody-lectin chimeras for glyco-immune checkpoint blockade
Nature Biotechnology 2025cited by 4position: firstdoi
982 Targeting glycans for cancer immunotherapy
Regular and Young Investigator Award Abstracts 2025cited by 0position: firstdoi
Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer
Journal of Clinical Investigation 2024cited by 37position: middledoi
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
Proceedings of the National Academy of Sciences 2023cited by 63position: middledoi
The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation
Journal of Biological Chemistry 2023cited by 36position: middledoi
Rapid biosynthesis of glycoprotein therapeutics and vaccines from freeze-dried bacterial cell lysates
Nature Protocols 2023cited by 29position: firstdoi
Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection
Nature Genetics 2022cited by 142position: middledoi
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
Blood Advances 2022cited by 84position: middledoi
On-demand biomanufacturing of protective conjugate vaccines
Science Advances 2021cited by 129position: firstdoi
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
ACS Central Science 2021cited by 66position: middledoi
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
ChemRxiv 2020cited by 6position: middledoi
Synthetic Siglec-9 Agonists Inhibit Neutrophil Activation Associated with COVID-19
ChemRxiv 2020cited by 4position: middledoi
A cell-free biosynthesis platform for modular construction of protein glycosylation pathways
Nature Communications 2019cited by 143position: middledoi
BioBits Health: Classroom Activities Exploring Engineering, Biology, and Human Health with Fluorescent Readouts
ACS Synthetic Biology 2019cited by 66position: firstdoi
Single-pot glycoprotein biosynthesis using a cell-free transcription-translation system enriched with glycosylation machinery
Nature Communications 2018cited by 215position: middledoi
BioBits™ Explorer: A modular synthetic biology education kit
Science Advances 2018cited by 144position: middledoi
BioBits™ Bright: A fluorescent synthetic biology education kit
Science Advances 2018cited by 119position: firstdoi
A cell‐free platform for rapid synthesis and testing of active oligosaccharyltransferases
Biotechnology and Bioengineering 2017cited by 98position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nicholas M. Riley · University of Washington9 papers (2020–2025)Carolyn R. Bertozzi · Stanford University9 papers (2020–2025)Michael C. Jewett · Northwestern University7 papers (2017–2023)Matthew P. DeLisa · Cornell University5 papers (2017–2023)Thapakorn Jaroentomeechai · University of Copenhagen4 papers (2017–2023)Simon Wisnovsky · University of British Columbia4 papers (2023–2025) · 4 papers (2020–2023) · 4 papers (2018–2021)Samuel Yang · Palo Alto University3 papers (2020–2021)Rachel S. Dubner · UPMC Hillman Cancer Center3 papers (2018–2021)Aravind Natarajan · Stanford University3 papers (2017–2019)Kari C. Nadeau · Harvard University3 papers (2020–2021) · 3 papers (2017–2023)Angela J. Rogers · Palo Alto University3 papers (2020–2021)Catherine A. Blish · Stanford University3 papers (2020–2021)Thanmayi Ranganath · All India Institute of Medical Sciences Raipur3 papers (2020–2021)Aaron J. Wilk · Stanford Medicine3 papers (2020–2021)Ally Huang · Massachusetts Institute of Technology2 papers (2018–2019)Jeffrey V. Ravetch · Rockefeller University2 papers (2025–2025) · 2 papers (2022–2023)